Alkermes Investigational Site

Jamaica, New York 11432

0 studies enrolling now · 8 studies all time

What they study most

Alcohol Use Disorder, Major Depressive Disorder, Refractory Major Depressive Disorder, Schizophrenia

Studies at this site

• Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS) — Completed
• A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder — Completed
• A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia — Completed
• A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD) — Stopped early
• A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD) — Completed
• A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study) — Completed
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 Study — Completed
• A Long-Term Safety Study of ALKS 5461 — Completed